GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Tax Provision

Labiana Health (XMAD:LAB) Tax Provision : €-1.27 Mil (TTM As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Tax Provision?

Labiana Health's tax provision for the six months ended in Dec. 2022 was €-0.89 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2022 was €-1.27 Mil.


Labiana Health Tax Provision Historical Data

The historical data trend for Labiana Health's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Tax Provision Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Tax Provision
0.53 0.01 -1.27

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Tax Provision - - -0.38 -0.89

Labiana Health Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.